SGLT2 in type 2 diabetes: a systematic review and meta-analysis
收藏DataCite Commons2020-08-03 更新2026-05-07 收录
下载链接：
http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42015006975
下载链接
链接失效反馈官方服务：
资源简介：
Systematic review protocol registration
应用场景：
创建时间：
2015-08-04
相关数据集
The efficacy and safety of SGLT2 inhibitors combined with ACEI/ARBs in the treatment of type 2 diabetes mellitus: A systematic review and meta-analysis
Supplementary Material 1: The risk of bias of enrolled trails according to version 2 of the Cochrane risk-of-bias tool. (A): The graph of risk of bias; (B): The summary of risk of bias. Supplementary
Mendeley Data2020-06-13 更新00
The efficacy and safety of SGLT2 inhibitors combined with ACEI/ARBs in the treatment of type 2 diabetes mellitus: A systematic review and meta-analysis
Supplementary Material 1: The risk of bias of enrolled trails according to version 2 of the Cochrane risk-of-bias tool. (A): The graph of risk of bias; (B): The summary of risk of bias. Supplementary
Mendeley Data00
Supplementary Material for: The Effects of SGLT2 Inhibitors on Cardiovascular and Renal Outcomes in Diabetic Patients: A Systematic Review and Meta-Analysis
Background: Previous meta-analyses demonstrated the benefits of sodium-glucose cotransporter 2 inhibitors (SGLT2i) primarily on patients with established atherosclerotic cardiovascular disease (ASCVD)
Figshare2019-11-19 更新00
The efficacy and safety of SGLT2 inhibitors combined with ACEI/ARBs in the treatment of type 2 diabetes mellitus: A systematic review and meta-analysis
Supplementary Material 1: The risk of bias of enrolled trails according to version 2 of the Cochrane risk-of-bias tool. (A): The graph of risk of bias; (B): The summary of risk of bias. Supplementary
NIAID Data Ecosystem60
Supplementary Material for: The Effects of SGLT2 Inhibitors on Cardiovascular and Renal Outcomes in Diabetic Patients: A Systematic Review and Meta-Analysis
Background: Previous meta-analyses demonstrated the benefits of sodium-glucose cotransporter 2 inhibitors (SGLT2i) primarily on patients with established atherosclerotic cardiovascular d
DataCite Commons2020-08-26 更新90
